Effects of the modified Renshen Yangrong granule and modified Renshen Yangrong decoction pieces on Qi deficiency syndrome: a randomized, controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-17011555

Enrollment

Unknown

Registered

2017-06-03

Start date

2017-06-15

Completion date

Unknown

Last updated

2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Qi deficiency syndrome

Interventions

Granule group:modified Renshen Yangrong Granule

decoction pieces group:modified Renshen Yangrong decoction pieces

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients meet the diagnosis of Qi deficiency syndrome; 2. Aged 18-65 years old; 3. All patients involved in this study must sign informed consents. Those who meet all the above conditions can be selected into the study.

Exclusion criteria

Exclusion criteria: 1. Qi deficiency syndrome caused by serious illness; 2. Patients with mental disease; 3. Pregnant or lactating patients; 4. Patients with severe accompanied symptoms. Those who meet any one of the above conditions would be excluded.

Design outcomes

Primary

Measure	Time frame
clinical efficacy;the scores of fatigue scales;expression frequency of CD4+;expression frequency of CD4+;expression frequency of Treg;content of IL-6;content of IL-6;content of IL-10;content of TNF-a;content of TGF-ß;	—

Countries

China

Contacts

Public ContactPing Wang

Hubei University of Chinese Medicine

pwang54@yahoo.com.cn+86 13971124658

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026